top of page
Cluster News
Standardize and scale tumor organoids to accelerate innovation in oncology.
On April 7, 2026, the Ecosystem Breakfast took place on the theme " Standardize and scale tumor organoids to accelerate innovation in oncology"; the replay is now available. With : Benjamin Saulnier: CEO of Cellura (SoftCell Therapeutics) . Access the replay
Apr 7
Alternative Species in Regulatory Toxicology: How to Reduce Your Budget While Preserving Scientific Robustness
On February 17, 2026, the Ecosystem Breakfast took place on the theme "Alternative Species in Regulatory Toxicology: How to Reduce Your Budget While Preserving Scientific Robustness " ; the replay is now available. With : Alexandre Bidaut Head of Alliance Management, ERBC Group Trained as a veterinary pathologist, Alexandre has been coordinating regulatory and non-regulatory preclinical studies for over 20 years within pharmaceutical companies and contract research organi
Feb 17
Reinventing liquid biopsy: towards integrative and personalized medicine
On January 27, 2026, the Ecosystem Breakfast took place on the theme "Reinventing liquid biopsy: towards integrative and personalized medicine " ; the replay is now available. With : Aline Cerf, SmartCatch Access the replay
Jan 28
What uses are there for ARCAD databases?
On January 13, 2026, the Ecosystem Breakfast took place on the theme " What uses are there for ARCAD databases?" , the replay is now available With : Ségolène de Retz is Chief Executive Officer of the Fondation ARCAD . Jean-Baptiste Bachet , MD, PhD, is a digestive oncologist specialized in colorectal and pancreatic cancers. He is involved in numerous clinical and translational research studies and is a member of GERCOR (Groupe d'Étude et de Recherche Clinique en
Jan 13
Detection of Minimal Residual Disease (MRD): A Highly Sensitive Tool for Monitoring Cancer Patients
The Ecosystem Breakfast took place on December 16, 2025, moderated by Céline Capéra , Head of Sales, IntegraGen, and Charles Marcaillou , Head of R&D, IntegraGen. and Séverine Matin-Lannerée , PhD, Head of Quality, IntegraGen The replay of the presentation on the topic " Detection of Minimal Residual Disease (MRD): A Highly Sensitive Tool for Monitoring Cancer Patients " is now available . Access the replay
Dec 17, 2025
Platform for ex-vivo modeling of cancers and functional screenings (OrganoScreen).
On December 2, 2025, the Ecosystem Breakfast , moderated by Pierre Savagner and Julie Rivière , took place on the theme " Ex-vivo modeling platform for cancers and functional screenings (OrganoScreen ). " The replay is now available . Access the replay
Dec 3, 2025
Scientific Due Diligence for Biotech and Pharma companies: how to share your most strategic data leveraging AI
On November 18, 2025, the Ecosystem Breakfast , moderated by Kahéna Yahiaoui of Intralinks , took place on the theme " Scientific Due Diligence for Biotech and Pharma companies: how to share your most strategic data leveraging AI. " The replay is now available . Access the replay View the presentation
Nov 18, 2025
EU vs. US regulatory pathways: key differences every biotech should know
On October 21, 2025, the Ecosystem Breakfast took place, hosted by Claire Dziengelewski, PhD , Senior Project Manager & Team Leader, and Jonathan Kearsey , Co-founder & Managing Director, Leads To Development , on the theme " EU vs. US regulatory pathways: key differences every biotech should know " , the replay is now available Access the replay View the presentation
Oct 23, 2025
Combining Liquid Biopsy and Epigenomics to Advance Cancer Biomarker Discovery: Technologies and Case Studies
On October 7, 2025, the Ecosystem Breakfast took place, hosted by Anaïs Dabbadie EMEA Biopharma Business Developer at Hologic Diagenode,...
Oct 7, 2025
Enabling precision proteomics with Olink technology to identify markers for risk prediction, diagnosis and prognosis
On September 23, 2025, the Ecosystem Breakfast took place, hosted by Anissa Lamarque PhD, Business Development Director UKI & France at...
Sep 23, 2025
Next generation proteomics in clinical and translational research
On September 9, 2025, the Ecosystem Breakfast took place, hosted by Amaury LACHAUD, PhD, Vice-President EMEA – Biognosys AG and Juan...
Sep 9, 2025
Single-Cell & Spatial Transcriptomics: Driving Precision Oncology Forward
On May 27 2025, Alban Bessede from Explicyte hosted the Ecosystem Breakfast on the theme of ‘Single-Cell & Spatial Transcriptomics:...
May 27, 2025
Dose escalation design in oncology phase I studies: from traditional 3+3 design to more efficient design
On May 13, 2025, the Ecosystem Breakfast took place, hosted by Cécile Lafon, biostatistician, Keyrus Life Science , on the theme "Dose...
May 20, 2025
Using ready-to-use cells for functional potency assays to accelerate mAbs characterization
On 29 April 2025, the Ecosystem Breakfast was hosted by Florian Mignot (Cell Based Assay Specialist) Promega France, on the theme ‘Using...
May 2, 2025
A new way of seeing and understanding biology thanks to Abbelight Nanoscopy
On April 1, 2025, the Ecosystem Breakfast took place, hosted by Cataldo Schietroma and Quentin Lubart, Abbelight , on the theme "A new...
Apr 2, 2025
Advances in cellular and multi-omics analysis for cancer research and therapeutic development.
On March 18, 2025, the Ecosystem Breakfast took place, hosted by Hervé Chaulet (Market Specialist, Molecular and Biological Research...
Mar 19, 2025
Advancing Cancer Research with Patient Derived Xenograft and PDX-Derived Organoids: Insights into Cancer Stem Cells and Metastasis
On March 4, 2025, the ecosystem breakfast took place on the theme: " Advancing Cancer Research with Patient Derived Xenograft and...
Mar 6, 2025
Advancing your Molecules into Clinical batches – The CMC journey
On 11 February 2025, the ecosystem breakfast was held on the theme: ‘Advancing your Molecules into Clinical batches - The CMC journey’....
Feb 13, 2025
Overview of current Spatial Biology & Single Cell omics proposed at AMMICa
On January 14, 2025, the ecosystem breakfast took place on the theme: "Overview of current Spatial Biology & Single Cell omics proposed...
Jan 16, 2025
Multi-omics Single Cell DNA Analysis resolves understanding of cancer disease and the therapeutic strategies to improve clinical outcomes
On December 14, 2024, the ecosystem breakfast took place on the theme: "Multi-omics Single Cell DNA Analysis resolves understanding of...
Dec 18, 2024
Cluster News
In Villejuif, the Paris-Saclay Cancer Cluster deploys an operational model to accelerate innovation in oncology
Villejuif, February 4, 2026 - On World Cancer Day , the Paris-Saclay Cancer Cluster (PSCC) is hosting the 3rd edition of its PSCC Innovation Forum in Villejuif. More than 700 oncology stakeholders -researchers, clinicians, start-ups, industrial players, investors, and patient representatives - are gathering around a shared conviction: t he future of oncology now lies in the ability to rapidly translate scientific innovation into tangible clinical impact. Each year, nearly 4
Feb 4
(In French) Hack4Hope 2025 : Ensemble pour transformer la prise en charge des cancers pédiatriques
Une deuxième édition ambitieuse dédiée aux cancers de l’enfant et de l’adolescent , organisée par le PSCC et son Childhood Cancer Working Group, avec le soutien de LifeArc, Foundation S, Imagine for Margo, Sanofi et Bristol Myers Squibb. 9 projets finalistes sélectionnés parmi 24 candidatures, couvrant thérapies innovantes, IA, diagnostics, nanomédecine et soutien aux familles. 4 gagnants distingués par le jury : Kindling Bio (1er Prix), MSInsight (2e Prix), Hippoxis (3e Pr
Dec 5, 2025
(In French) À The Hive, le Central Lab et l’Innovation Center dévoilent leur offre aux sociétés innovantes en oncologie du PSCC
Premier événement scientifique organisé au sein de The Hive , bâtiment totem du biocluster, au cœur du Campus Grand Parc Lancement du Central Lab , bientôt opérationnel pour accompagner les projets précliniques et cliniques Déploiement de l’ Innovation Center , une offre modulable destinée aux jeunes start-ups Présentation de deux nouveaux locataires de The Hive : Valerio Therapeutics , et Signadori Bio Villejuif, le 04 décembre 2025 – Organisée à The Hive, bâtiment de 25
Dec 4, 2025
(in french) Déploiement du système robotique ION : La biopsie robot-assistée qui révolutionne le traitement et le diagnostic du cancer du poumon est en place à l’Hôpital Marie-Lannelongue
Paris, France, 11 septembre, 2025 — L’Hôpital Marie-Lannelongue, le Centre International des Cancers Thoraciques (CICT) et le Paris...
Sep 12, 2025
Cluster News
Pediatric Cancers: what to anticipate and what ressources are available
An exclusive webinar led by Pr. GILLES VASSAL, Pediatric Oncologist at Gustave Roussy, and member of ITCC Consortium, on « 𝙋𝙚𝙙𝙞𝙖𝙩𝙧𝙞𝙘 𝘾𝙖𝙣𝙘𝙚𝙧𝙨 : 𝙬𝙝𝙖𝙩 𝙩𝙤 𝙖𝙣𝙩𝙞𝙘𝙞𝙥𝙖𝙩𝙚 𝙖𝙣𝙙 𝙬𝙝𝙖𝙩 𝙧𝙚𝙨𝙨𝙤𝙪𝙧𝙘𝙚𝙨 𝙖𝙧𝙚 𝙖𝙫𝙖𝙞𝙡𝙖𝙗𝙡𝙚 ? »
3 days ago
Standardize and scale tumor organoids to accelerate innovation in oncology.
On April 7, 2026, the Ecosystem Breakfast took place on the theme " Standardize and scale tumor organoids to accelerate innovation in oncology"; the replay is now available. With : Benjamin Saulnier: CEO of Cellura (SoftCell Therapeutics) . Access the replay
Apr 7
Understanding innovative purchasing in hospitals with the RESAH
Understanding innovative purchasing in hospitals with the RESAH
Mar 27
New start-ups join the PSCC BOOST programme
Five innovative oncology-focused projects have been selected through the BOOST programme and join the Paris Saclay Cancer Cluster (PSCC), further strengthening the diversity, scientific excellence and ambition of the ecosystem. From cell therapies to gene delivery, theranostics, vaccines and advanced imaging technologies , these projects illustrate the breadth of approaches supported by PSCC to accelerate the translation of scientific breakthroughs into tangible impact for p
Mar 25
Cluster News
New start-ups join the PSCC BOOST programme
Five innovative oncology-focused projects have been selected through the BOOST programme and join the Paris Saclay Cancer Cluster (PSCC), further strengthening the diversity, scientific excellence and ambition of the ecosystem. From cell therapies to gene delivery, theranostics, vaccines and advanced imaging technologies , these projects illustrate the breadth of approaches supported by PSCC to accelerate the translation of scientific breakthroughs into tangible impact for p
Mar 25
New start-ups join the PSCC BOOST programme
For the beginning of 2026, five innovative oncology-focused projects were successful in the selection process and join the BOOST programme of the Paris Saclay Cancer Cluster (PSCC), further strengthening the diversity, scientific excellence and ambition of the ecosystem. From novel therapeutic modalities to next-generation biologics , these projects illustrate the breadth of approaches supported by PSCC to accelerate the translation of breakthrough science into tangible imp
Jan 7
9 new projects supported by the PSCC
From diagnosis to therapies, from molecules to algorithms: innovation takes multiple forms within the Paris Saclay Cancer Cluster (PSCC)....
Sep 25, 2025
8 new projects to be supported by the PSCC
We are thrilled to announce that 5 new projects have been selected by the PSCC to benefit from its support: Carla Biotherapeutics : A...
Jun 23, 2025
Cluster News
Les Echos - A Villejuif, le cluster de l'oncologie prend de l'ampleur (in french)
Huit entreprises, 250 salariés et un fonds de subvention de 2,5 millions d'euros… Le Paris-Saclay Cancer Cluster met les bouchées doubles à Villejuif pour accélérer le passage de la recherche à la fabrication de traitement contre le cancer. Le Paris-Saclay Cancer Cluster met les bouchées doubles. Ce cluster, financé par l'Etat à hauteur de 100 millions d'euros, développe un pôle consacré à l'oncologie et à la déclinaison de la recherche en traitement pour trouver des solution
Feb 6
Mind Health - Le PSCC dévoile ses ambitions pour 2026 (in French)
Le Paris-Saclay Cancer Cluster (PSCC), le biocluster dédié à l'oncologie, a présenté le 4 février un bilan de son activité depuis sa création en 2022 à l'occasion du PSCC Innovation Forum 2026. Son Campus, doté d'un investissement de 1,8 Mds €, sort progressivement de terre : 45 000 m² de laboratoires et de bureaux sont opérationnels depuis 2025. En janvier, sept entreprises, dont Sanofi et One Biosciences, ont déjà rejoint le cluster et le PSCC vise l'installation de plus de
Feb 6
L'Express - Visite exclusive au cœur du "Paris-Saclay Cancer Cluster" : "Grâce à cet incubateur, tout va plus vite (in french)
Reportage. Sous l’impulsion d’Emmanuel Macron, la France tente d’ériger à Villejuif un incubateur géant pour aider les scientifiques à transformer leurs idées en médicaments. C'est vrai que l'on s’y perd dans ces couloirs où rien n’est indiqué, au milieu de toutes ces salles nues, qui attendent encore qu’on les habille de meubles et de moquettes. Le "Paris-Saclay Cancer Cluster", projet d’incubateur inédit en France, n’est pas tout à fait fini, et cela se devine à tous ces sa
Feb 3
L'Express - Cancer, les vrais progrès de la science : "La frontière de la guérison a bougé"
Sciences et santé. Les médecins arrivent désormais à prolonger la vie de certains patients atteints de tumeurs métastatiques. Une révolution, même si le cancer reste la première cause de décès dans notre pays. On dit de Valérie, 56 ans, qu’elle a "bonne mine". Qu’elle n’a pas l’air "malade". Peut-être est-ce dû à cet infatigable entrain, elle qui a toujours eu une énergie "débordante" et mille projets à la fois, cadre dans l’assurance et élue d’une petite commune du sud de la
Nov 26, 2025
Cluster News
Pediatric Cancers: what to anticipate and what ressources are available
An exclusive webinar led by Pr. GILLES VASSAL, Pediatric Oncologist at Gustave Roussy, and member of ITCC Consortium, on « 𝙋𝙚𝙙𝙞𝙖𝙩𝙧𝙞𝙘 𝘾𝙖𝙣𝙘𝙚𝙧𝙨 : 𝙬𝙝𝙖𝙩 𝙩𝙤 𝙖𝙣𝙩𝙞𝙘𝙞𝙥𝙖𝙩𝙚 𝙖𝙣𝙙 𝙬𝙝𝙖𝙩 𝙧𝙚𝙨𝙨𝙤𝙪𝙧𝙘𝙚𝙨 𝙖𝙧𝙚 𝙖𝙫𝙖𝙞𝙡𝙖𝙗𝙡𝙚 ? »
3 days ago
Standardize and scale tumor organoids to accelerate innovation in oncology.
On April 7, 2026, the Ecosystem Breakfast took place on the theme " Standardize and scale tumor organoids to accelerate innovation in oncology"; the replay is now available. With : Benjamin Saulnier: CEO of Cellura (SoftCell Therapeutics) . Access the replay
Apr 7
Understanding innovative purchasing in hospitals with the RESAH
Understanding innovative purchasing in hospitals with the RESAH
Mar 27
New start-ups join the PSCC BOOST programme
Five innovative oncology-focused projects have been selected through the BOOST programme and join the Paris Saclay Cancer Cluster (PSCC), further strengthening the diversity, scientific excellence and ambition of the ecosystem. From cell therapies to gene delivery, theranostics, vaccines and advanced imaging technologies , these projects illustrate the breadth of approaches supported by PSCC to accelerate the translation of scientific breakthroughs into tangible impact for p
Mar 25
bottom of page